Report copyright - Review Report Pharmaceuticals and Medical Devices Agency · 5 6.1 Clinical pharmacology The pharmacokinetics (PK) of regorafenib and its metabolites (M-2 [pyridine N-oxide form] and
Please pass captcha verification before submit form